Literature DB >> 27484631

Cognitive performance, fatigue and event-related potentials in patients with clinically isolated syndrome.

Anna Pokryszko-Dragan1, Edyta Dziadkowiak2, Mieszko Zagrajek2, Krzysztof Slotwinski2, Ewa Gruszka2, Malgorzata Bilinska2, Ryszard Podemski2.   

Abstract

OBJECTIVES: Cognitive impairment and fatigue are regarded as important aspects of multiple sclerosis. The aim of this study was to evaluate cognitive performance, the level of fatigue and parameters of event-related potentials (ERP) in patients diagnosed with clinically isolated syndrome (CIS). PATIENTS AND METHODS: The study comprised 44 patients with CIS and 45 healthy controls. Cognitive performance was assessed using the Brief Repeatable Battery of Neuropsychological Tests (BRBNT), fatigue - using the Fatigue Severity Scale (FSS) and Modified Fatigue Impact Scale (MFIS). Auditory ERP were performed and the parameters of N200 and P300 components were analyzed. Neuropsychological and electrophysiological measures were referred to clinical and radiological features of the disease activity.
RESULTS: Forty five% of patients failed in at least one test from BRBNT, mainly within the domains of memory and attention. In 18% of patients FSS corresponded with moderate or severe fatigue. The mean latency of N200 and P300 was significantly longer and amplitude of P300 was lower in those patients with CIS than in the controls. Significant correlations were found between the results of MFIS and tests evaluating verbal memory and attention, as well as between N200 latency and results of tests for verbal memory.
CONCLUSIONS: Cognitive performance and fatigue deserve attention from the earliest clinical stage of MS. Abnormalities of event-related potentials in CIS suggest early impact of the disease on functional neural networks.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinically isolated syndrome; Cognition; Event-related potentials; Fatigue; Multiple sclerosis

Mesh:

Year:  2016        PMID: 27484631     DOI: 10.1016/j.clineuro.2016.07.022

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

Review 1.  The Potential Role of Neurophysiology in the Management of Multiple Sclerosis-Related Fatigue.

Authors:  Fioravante Capone; Francesco Motolese; Emma Falato; Mariagrazia Rossi; Vincenzo Di Lazzaro
Journal:  Front Neurol       Date:  2020-04-22       Impact factor: 4.003

2.  Magnetoencephalography and High-Density Electroencephalography Study of Acoustic Event Related Potentials in Early Stage of Multiple Sclerosis: A Pilot Study on Cognitive Impairment and Fatigue.

Authors:  Damiano Paolicelli; Alessia Manni; Antonio Iaffaldano; Giusy Tancredi; Katia Ricci; Eleonora Gentile; Rosa Gemma Viterbo; Silvia Giovanna Quitadamo; Marina de Tommaso; Maria Trojano
Journal:  Brain Sci       Date:  2021-04-09

3.  Multimodal Evoked Potentials as Potential Biomarkers of Disease Activity in Patients With Clinically Isolated Syndrome.

Authors:  Edyta Dziadkowiak; Małgorzata Wieczorek; Mieszko Zagrajek; Justyna Chojdak-Łukasiewicz; Ewa Gruszka; Sławomir Budrewicz; Anna Pokryszko-Dragan
Journal:  Front Neurol       Date:  2022-02-08       Impact factor: 4.003

4.  Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review.

Authors:  Abril Oliva Ramirez; Alexander Keenan; Olivia Kalau; Evelyn Worthington; Lucas Cohen; Sumeet Singh
Journal:  BMC Neurol       Date:  2021-12-02       Impact factor: 2.474

5.  Motor Imagery as a Function of Disease Severity in Multiple Sclerosis: An fMRI Study.

Authors:  Andrea Tacchino; Catarina Saiote; Giampaolo Brichetto; Giulia Bommarito; Luca Roccatagliata; Christian Cordano; Mario A Battaglia; Gian L Mancardi; Matilde Inglese
Journal:  Front Hum Neurosci       Date:  2018-01-11       Impact factor: 3.169

6.  Assessment of factors associated with depression and anxiety among pwMS in Saudi Arabia.

Authors:  Safanah AlSaeed; Nuha M Alkhawajah; Mohsen Ayyash; Salman Aljarallah; Rola Alarieh; Amani Abu-Shaheen
Journal:  BMC Neurol       Date:  2022-03-25       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.